ADA and Alzheimer disease: , VGF, NPTX2, SCN3B; Supplementary Figure S11 A-M) overall showed similar trends towards decrease in late-stage AD, though individual abundance changes were more pronounced, reaching clear significance in the CU/SCIA- vs. ADA+ comparison.